Last reviewed · How we verify

NCT06825897: DIRECT

Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe

Recruiting now NA Last updated 13 March 2026
What this trial tests

NA trial testing Conventional Triage for Mechanical Thrombectomy in Stroke, Acute in 2,039 participants. Currently enrolling.

Timeline
27 January 2026
Primary endpoint
30 April 2028
30 April 2028

Quick facts

Lead sponsorSantiago Ortega Gutierrez
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposetreatment
Enrollment2,039
Start date27 January 2026
Primary completion30 April 2028
Estimated completion30 April 2028
Sites6 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Santiago Ortega Gutierrez

Who can join

18 and older, any sex, with Stroke, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare two strategies for treating adults with suspected large vessel occlusion stroke within 7 hours of symptom onset. Researchers will evaluate whether direct transfer to the neurointerventional angiography suite improves recovery and reduces disability compared to the conventional approach of first being evaluated in the emergency department. The study will also assess safety and other health outcomes to guide care for stroke patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Neurointerventional Advances in 2025.
    Mehta A, Sheth SA, Jadhav AP. · · 2026 · PMID 42088336 · DOI 10.1161/svin.125.002280

Verify or expand the search:

Other recruiting trials for Stroke, Acute

Currently open trials in the same condition.

Other Santiago Ortega Gutierrez trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06825897.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing